Carboplatin recalls
Carboplatin products have been recalled 4 times, most recently on 13 Feb 2013. The recalling company is usually Hospira. The most common reason is particulate matter.
Total recalls4since 2012
Last 12 months0reported
Class I250% of total
Ongoing0latest 13 Feb 2013
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 50%Class II 1 25%Class III 1 25%
Why carboplatin is recalled
Companies
Product types
By year
All carboplatin recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Carboplatin Injection, 600 mg/ (10 mg/mL), Cytotoxic Agent recalledCarboplatin | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS I | Carboplatin Injection, 450 mg/ (10 mg/mL), Cytotoxic Agent recalledCarboplatin | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS II | Carboplatin Injection, 10 mg/mL Multi-Dose Vial recalled by HospiraCarboplatin | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS III | Carboplatin Injection, 10 mg/mL, a) multi-dose vials recalled by HospiraCarboplatin | Hospira | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.